Production (Stage)
U
Bellicum Pharmaceuticals, Inc. BLCM
OTC PK
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Revenue 0.00% -- -- 0.00% -80.00%
Total Other Revenue -- -- -- -- --
Total Revenue 0.00% -- -- 0.00% -80.00%
Cost of Revenue -96.16% -5.52% 60.86% 56.63% 7.91%
Gross Profit 112.60% 5.52% -60.68% -64.62% -333.98%
SG&A Expenses 14.90% 56.01% -1.10% -3.29% -21.77%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -78.27% 8.11% 45.70% 40.03% 1.69%
Operating Income 89.20% -8.11% -45.56% -43.95% -136.55%
Income Before Tax 89.42% -83.75% -6.66% -344.76% -685.00%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 89.42% -83.75% -6.66% -344.84% -685.00%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 89.42% -83.75% -6.66% -344.84% -685.00%
EBIT 89.20% -8.11% -45.56% -43.95% -136.55%
EBITDA 89.22% -8.13% -45.64% -44.34% -138.09%
EPS Basic 89.44% -83.67% -6.60% -224.77% -409.52%
Normalized Basic EPS 89.40% -83.72% -6.58% -224.73% -289.62%
EPS Diluted 89.44% -83.67% -4.64% -227.22% -434.29%
Normalized Diluted EPS 89.40% -83.72% -6.58% -225.60% -291.36%
Average Basic Shares Outstanding 0.24% 0.02% 0.05% 96.24% 205.01%
Average Diluted Shares Outstanding 0.24% 0.02% 0.05% 94.93% 202.42%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --